Pharmacologic Treatments of Acute Episodic Migraine Headache in Outpatient Settings: A Clinical Guideline From the American College of Physicians

医学 偏头痛 指南 家庭医学 替代医学 重症监护医学 精神科 物理疗法 病理
作者
Amir Qaseem,Jeffrey A. Tice,Itziar Etxeandia‐Ikobaltzeta,Timothy J Wilt,Curtis S. Harrod,Thomas G. Cooney,Carolyn J. Crandall,Carolyn J. Crandall,Lauri A. Hicks,Lauri A. Hicks,Timothy J Wilt,Ethan M. Balk,Ethan M. Balk,Thomas G. Cooney,J. Thomas Cross,J. Thomas Cross,Nick Fitterman,Nick Fitterman,Johanna Miller Lewis,Johanna Miller Lewis
出处
期刊:Annals of Internal Medicine [American College of Physicians]
卷期号:178 (4): 571-578 被引量:15
标识
DOI:10.7326/annals-24-03095
摘要

DESCRIPTION: The American College of Physicians (ACP) developed this guideline based on the best available evidence on the comparative benefits and harms of pharmacologic treatments of acute episodic migraine headache, patients' values and preferences, and economic evidence about these pharmacologic treatments. METHODS: This guideline is based on a systematic review and network meta-analysis of the comparative benefits and harms of pharmacologic treatments of acute episodic migraine headaches, as well as systematic reviews of patients' values and preferences and comparative cost-effectiveness analyses. The Clinical Guidelines Committee evaluated the following clinical outcomes using the GRADE (Grading of Recommendations, Assessment, Development and Evaluation) approach: pain freedom and pain relief at 2 hours; sustained pain freedom and sustained pain relief up to 48 hours; need for rescue medication within 24 hours; nausea, vomiting, and restored physical function at 2 hours; and overall and serious adverse events (AEs). Additional data on AEs were captured through U.S. Food and Drug Administration medication labels. AUDIENCE AND POPULATION: The audience for this clinical guideline is physicians and other clinicians. The population is adults with acute episodic migraine headache (defined as 1 to 14 headache days per month) managed in outpatient settings. RECOMMENDATION 1: ACP recommends that clinicians add a triptan to a nonsteroidal anti-inflammatory drug to treat moderate to severe acute episodic migraine headache in outpatient settings for nonpregnant adults who do not respond adequately to a nonsteroidal anti-inflammatory drug (strong recommendation; moderate-certainty evidence). RECOMMENDATION 2: ACP suggests that clinicians add a triptan to acetaminophen to treat moderate to severe acute episodic migraine headache in outpatient settings for nonpregnant adults who do not respond adequately to acetaminophen (conditional recommendation; low-certainty evidence).
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
xixihaha发布了新的文献求助10
1秒前
情怀的应助被zyy采纳,获得30
1秒前
Nana完成签到,获得积分10
2秒前
无花果的应助被xiaobai采纳,获得10
2秒前
2秒前
鲤鱼鑫磊发布了新的文献求助10
3秒前
SSSYYY完成签到,获得积分10
4秒前
dde发布了新的文献求助10
4秒前
4秒前
ZEcholy完成签到,获得积分10
5秒前
yansiyi发布了新的文献求助10
5秒前
xiaofengyyy完成签到,获得积分10
6秒前
1111发布了新的文献求助10
6秒前
Orange的应助被xhy777采纳,获得10
6秒前
xixihaha完成签到,获得积分10
6秒前
王德荣完成签到,获得积分10
7秒前
不安寒风完成签到,获得积分10
7秒前
Su完成签到 ,获得积分10
8秒前
脑洞疼的应助被Lee采纳,获得10
8秒前
电风扇完成签到,获得积分10
9秒前
zxcharm完成签到,获得积分0
9秒前
Jared发布了新的文献求助10
9秒前
我是谁的应助被哈哈镜阿姐采纳,获得30
10秒前
11秒前
Yob完成签到,获得积分10
11秒前
乐乐的应助被zyy采纳,获得30
12秒前
规划计划完成签到 ,获得积分10
12秒前
科研通AI6.2的应助被tjl采纳,获得10
13秒前
邱燈完成签到,获得积分10
14秒前
SciGPT的应助被外向的大狮子采纳,获得10
15秒前
15秒前
天天快乐的应助被6666采纳,获得10
15秒前
伶俐绿柏完成签到,获得积分10
16秒前
16秒前
传奇3的应助被JF123_采纳,获得10
16秒前
Owen的应助被yansiyi采纳,获得20
17秒前
eerrtt完成签到,获得积分10
18秒前
18秒前
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8187362
求助须知:如何正确求助?哪些是违规求助? 9575478
关于积分的说明 21841431
捐赠科研通 7785067
什么是DOI,文献DOI怎么找? 3434943
关于科研通互助平台的介绍 2559401
邀请新用户注册赠送积分活动 2481820